Revolutionizing Antibiotic Selection: AtbFinder’s Impact on Cystic Fibrosis Treatment
Source: HHMI BioInteractive Treatment of chronic respiratory infections, especially in individuals with cystic fibrosis (CF), has been challenging due to bacterial resistance and polymicrobial interactions. However, a recent study has introduced a breakthrough diagnostic approach named AtbFinder, which aims to transform antibiotic selection by considering the complexities of polymicrobial communities in the CF lung1. The …
Revolutionizing Antibiotic Selection: AtbFinder’s Impact on Cystic Fibrosis Treatment Read More »